Only 30% of patients respond well to a given obesity treatment, but typical treatment is ad hoc, wasting precious time and money. As Mayo Clinic obesity doctors, we've demonstrated that identifying a patient's specific type (aka phenotype) of obesity and personalizing their treatment produces twice the amount of weight loss. With exclusive tech from Mayo Clinic, we are commercializing our first product in the form of a simple blood test to bring forward precision medicine to weight-loss therapy.
Our tech helps patients double their weight loss with fewer side effects than conventional interventions (i.e. diet, meds, devices, surgery.)
Founded by 2 obesity doctors using exclusive tech from Mayo Clinic (patents pending).
The blood test has been clinically validated in 2 randomized controlled Mayo Clinic trials to predict obesity drug response at 90% accuracy.
Large market: over 40% of adults in the U.S. are obese).
People spend thousands of dollars each year trying to lose weight with no luck.
Projected price will be $600, competitively priced among other DNA tests with wellness/health coaching (range from $200 - $1000).
The Phenomix "PhenoTest" will help patients and their healthcare providers choose the most effective treatment, based on their unique biology, the first time.
Provisional patent on IP for blood test and phenotyping algorithms.